* Si quieres que hagamos difusión de tus artículos escríbenos a documentacion.iacs@aragon.es
Mucinous cystic liver neoplasm with invasive component and sarcomatous differentiation.
Aparicio-López D, Palomares-Cano A, Hörndler-Algarate C, Serrablo-Requejo A, Serradilla-Martín M.
Acta Chir Belg. 2023 Oct;123(5):577-580. doi: 10.1080/00015458.2022.2082061
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Botta C, Perez C, Larrayoz M, Puig N, Cedena MT, Termini R, Goicoechea I, Rodriguez S, Zabaleta A, Lopez A, Sarvide S, Blanco L, Papetti DM, Nobile MS, Besozzi D, Gentile M, Correale P, Siragusa S, Oriol A, González-Garcia ME, Sureda A, de Arriba F, Rios Tamayo R, Moraleda JM, Gironella M, Hernandez MT, Bargay J, Palomera L, Pérez-Montaña A, Goldschmidt H, Avet-Loiseau H, Roccaro A, Orfao A, Martinez-Lopez J, Rosiñol L, Lahuerta JJ, Blade J, Mateos MV, San-Miguel JF, Martinez Climent JA, Paiva B; Programa Para el Estudio de la Terapéutica en Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) cooperative group; iMMunocell study group.
Nat Commun. 2023 Sep 20;14(1):5825. doi: 10.1038/s41467-023-41562-6
Feasibility of a selective targeted strategy of HIV testing in emergency departments: a before-after study.
González Del Castillo J, Mirò E, Miguens I, Trenc P, Espinosa B, Piedrafita L, Pérez Elías MJ, Moreno S, García F, Villamor A, Carbó M, Gené E, Mirò Ò; Emergency HIV network investigators.
Eur J Emerg Med. 2023 Sep 20. doi: 10.1097/MEJ.0000000000001078
Consensus recommendations on the preventive treatment of migraine.
Calleja-Hernández MÁ, Guerrero-Peral ÁL, Irimia-Sieira P, Martínez-López I, Santos-Lasaosa S, Sarobe-Carricas M, López-Matencio JMS, Láinez-Andrés JM.
Farm Hosp. 2023 Sep 18:S1130-6343(23)00093-4. doi: 10.1016/j.farma.2023.07.002
CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro.
Lopez-Yus M, Frendo-Cumbo S, Del Moral-Bergos R, Garcia-Sobreviela MP, Bernal-Monterde V, Rydén M, Lorente-Cebrian S, Arbones-Mainar JM.
Am J Physiol Cell Physiol. 2023 Sep 18. doi: 10.1152/ajpcell.00291.2023
Prognostic impact of metformin in patients with type 2 diabetes mellitus and acute heart failure: Combined analysis of the EAHFE and RICA registries.
Povar-Echeverría M, Méndez-Bailón M, Martín-Sánchez FJ, Montero-Pérez-Barquero M, Carles-Trullàs J, Miró Ò.
Rev Clin Esp (Barc). 2023 Sep 17:S2254-8874(23)00106-6. doi: 10.1016/j.rceng.2023.09.007
Real-world persistence of initial targeted therapy strategy in monotherapy versus combination therapy in patients with chronic inflammatory arthritis.
Exposito L, Sánchez-Piedra C, Vela-Casasempere P, Moreno-Ramos MJ, Campos C, Bohorquez C, Manero J, Calvo-Gutiérrez J, Rodríguez-Lozano C, Ruiz-Montesino D, Busquets N, García-González J, Castrejón I, Alonso F, Bustabad S, Díaz-González F.
Eur J Clin Invest. 2023 Sep 16:e14095. doi: 10.1111/eci.14095
Mathematical reconstruction of the metabolic network in an in-vitro multiple myeloma model.
Vera-Siguenza E, Escribano-Gonzalez C, Serrano-Gonzalo I, Eskla KL, Spill F, Tennant D.
PLoS Comput Biol. 2023 Sep 15;19(9):e1011374. doi: 10.1371/journal.pcbi.1011374.
Biomarkers of Alzheimer’s disease and cerebrovascular disease in relation to depressive symptomatology in individuals with subjective cognitive decline.
Zapater-Fajarí M, Diaz-Galvan P, Cedres N, Rydberg Sterner T, Rydén L, Sacuiu S, Waern M, Zettergren A, Zetterberg H, Blennow K, Kern S, Hidalgo V, Salvador A, Westman E, Skoog I, Ferreira D.
J Gerontol A Biol Sci Med Sci. 2023 Sep 14:glad216. doi: 10.1093/gerona/glad216
Are physical therapy interventions effective in improving sleep in people with chronic pain? A systematic review and multivariate meta-analysis.
Calvo S, González C, Lapuente-Hernández D, Cuenca-Zaldívar JN, Herrero P, Gil-Calvo M.
Sleep Med. 2023 Sep 12;111:70-81. doi: 10.1016/j.sleep.2023.09.008
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA, Melisi D, Macarulla T, Pazo Cid R, Chandana SR, De La Fouchardière C, Dean A, Kiss I, Lee WJ, Goetze TO, Van Cutsem E, Paulson AS, Bekaii-Saab T, Pant S, Hubner RA, Xiao Z, Chen H, Benzaghou F, O’Reilly EM.
Lancet. 2023 Sep 11:S0140-6736(23)01366-1. doi: 10.1016/S0140-6736(23)01366-1
Clinical and molecular profiles in patients allergic to amaranthaceae.
Agulló-García A, Colás Sanz C, Martínez Lostao L, Salamanca Fernández G, Ferrer Clavería L, Cubero Saldaña JL, Lozano Andaluz SV, Carbajo Martínez E, Villalba Díaz MT.
J Investig Allergol Clin Immunol. 2023 Sep 7:0. doi: 10.18176/jiaci.0931.